TALPHERA, INC. — Director's Dealing 2018

Dec 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2018-12-14

Reporting Person: ASADORIAN RAFFI (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-14	Common Stock	P	5000	$2.7766	Acquired	52000	Direct

Footnotes

F1: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.7732 to $2,779 on December 14, 2018. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.